Position in GILD
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$3,941,049
-$291,339 QoQ
Shares Held
31,194
+2.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#638
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEVEL FOUR ADVISORY SERVICES, LLC holds $97,082,688 across 12 Drug Manufacturers - General names. GILD ranks #7 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
135,146 | $34,008,139 | |
| 2 | JNJ |
Johnson & Johnson
|
65,905 | $16,737,892 | |
| 3 | NVO |
Novo Nordisk A S
|
197,413 | $9,463,979 | |
| 4 | MRK |
Merck & Co., Inc.
|
73,273 | $9,415,580 | |
| 5 | LLY |
ELI LILLY & Co
|
7,377 | $8,848,195 | |
| 6 | AMGN |
Amgen Inc
|
15,638 | $5,662,832 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
31,194 | $3,941,049 | |
| 8 | AZN |
Astrazeneca PLC
|
15,186 | $2,879,569 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,941,049 | 31,194 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,232,388 | 30,368 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,561,055 | 29,013 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,987,010 | 26,910 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,918,652 | 26,325 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,839,953 | 34,270 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,128,571 | 33,870 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,855,171 | 34,055 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,217,063 | 32,314 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $242,677 | 3,313 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $268,386 | 3,313 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $287,020 | 3,830 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $343,346 | 4,455 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $406,138 | 4,895 | Shares | Sole | 2023-06-05 | |
| 2022-12-31 | $421,523 | 4,910 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $244,045 | 3,956 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $334,392 | 5,410 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $307,059 | 5,165 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $485,688 | 6,689 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $365,944 | 5,239 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $671,316 | 9,749 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $482,786 | 7,470 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $293,164 | 5,032 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $359,424 | 5,688 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $476,258 | 6,190 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $323,561 | 4,328 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||